
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Take a pictorial tour of Paris with the editors of Applied Clinical Trials
The Pont Alexandre III
The Grand Palais
Invalides
The Louvre
Napoleon III's Dining Room, The Louvre
over 20 years ago
Fighting for Europe's Futureover 20 years ago
Oracle Introduces Oracle® Clinical Data Repositoryover 20 years ago
Interview with Klaus Roseover 20 years ago
EU Innovation and Competitiveness





